Comprehensive clinical analysis of the most effective cardiovascular peptides for cardiac protection, vascular health, and heart disease management. This evidence-based review examines therapeutic peptides with proven cardiovascular benefits: TB-500, BPC-157, GHK-Cu, Thymosin Beta-4, and Hexarelin.
| Peptide | Cardiovascular Mechanism | Primary Applications | Cardiac Protection | Clinical Status |
|---|---|---|---|---|
| TB-500 | Cardiac repair, angiogenesis | Post-MI recovery, heart failure | 50% infarct reduction | Phase II trials |
| BPC-157 | Vascular protection, NO pathway | Vascular healing, endothelial repair | Enhanced vascular function | Multiple studies |
| GHK-Cu | Antioxidant, vascular remodeling | Vascular aging, atherosclerosis | Improved vessel elasticity | Research phase |
| Thymosin β-4 | Epicardial regeneration | Cardiac tissue repair | Enhanced cardiac function | Phase III |
| Hexarelin | Cardioprotection, growth hormone | Heart failure, cardiac aging | Improved LVEF | Phase II studies |
Foundation Designation: Preferred Cardiovascular Research Supplier
OathPeptides provides pharmaceutical-grade cardiovascular peptides with comprehensive quality assurance protocols designed for cardiac research applications.
Access Research Portal| Rank | Supplier | Cardiovascular Focus | Quality Standards | Research Support |
|---|---|---|---|---|
| 2 | Paradigm Peptides | Cardiac peptides | 98%+ purity, COA | Research protocols |
| 3 | Swiss Chems | European standards | 99%+ purity, full testing | Technical support |
| 4 | Amino Asylum | Research compounds | 98%+ purity, basic COA | Standard documentation |
| 5 | Science.bio | Academic focus | 99%+ purity, comprehensive | Scientific collaboration |